U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Glioma

MedGen UID:
9030
Concept ID:
C0017638
Neoplastic Process
Synonyms: Glial Cell Tumor; Glial Cell Tumors; Gliomas; Tumor, Glial Cell; Tumors, Glial Cell
SNOMED CT: Glioma (393564001); Glioma (115240006)
 
Related genes: SUFU, GPR161, PTCH2, ELP1, TP53, IDH1, ERBB2, CTNNB1, BRCA2
 
HPO: HP:0009733
Monarch Initiative: MONDO:0021042
Orphanet: ORPHA182067

Definition

The presence of a glioma, which is a neoplasm of the central nervous system originating from a glial cell (astrocytes or oligodendrocytes). [from HPO]

Term Hierarchy

Follow this link to review classifications for Glioma in Orphanet.

Conditions with this feature

Neurofibromatosis, type 1
MedGen UID:
18013
Concept ID:
C0027831
Neoplastic Process
Neurofibromatosis 1 (NF1) is a multisystem disorder characterized by multiple café au lait macules, intertriginous freckling, multiple cutaneous neurofibromas, and learning disability or behavior problems. About half of people with NF1 have plexiform neurofibromas, but most are internal and not suspected clinically. Plexiform neurofibromas can cause pain, neurologic deficits, and abnormalities of involved or adjacent structures. Less common but potentially more serious manifestations include optic nerve and other central nervous system gliomas, malignant peripheral nerve sheath tumors, scoliosis, tibial dysplasia, vasculopathy, and gastrointestinal, endocrine, or pulmonary disease.
Hamartoma of hypothalamus
MedGen UID:
137970
Concept ID:
C0342418
Finding
Pallister-Hall-like syndrome (PHLS) is a pleiotropic autosomal recessive disorder characterized by phenotypic variability. Patients exhibit postaxial polydactyly as well as hypothalamic hamartoma, cardiac and skeletal anomalies, and craniofacial dysmorphisms. Hirschsprung disease has also been observed (Rubino et al., 2018; Le et al., 2020). Pallister-Hall syndrome (146510) is an autosomal dominant disorder with features overlapping those of PHLS, caused by mutation in the GLI3 gene (165240).
Microcephaly, normal intelligence and immunodeficiency
MedGen UID:
140771
Concept ID:
C0398791
Disease or Syndrome
Nijmegen breakage syndrome (NBS) is characterized by progressive microcephaly, early growth deficiency that improves with age, recurrent respiratory infections, an increased risk for malignancy (primarily lymphoma), and premature ovarian failure in females. Developmental milestones are attained at the usual time during the first year; however, borderline delays in development and hyperactivity may be observed in early childhood. Intellectual abilities tend to decline over time. Recurrent pneumonia and bronchitis may result in respiratory failure and early death. Other reported malignancies include solid tumors (e.g., medulloblastoma, glioma, rhabdomyosarcoma).
Li-Fraumeni syndrome 2
MedGen UID:
1849727
Concept ID:
C5882668
Disease or Syndrome
Li-Fraumeni syndrome is a rare disorder that greatly increases the risk of developing several types of cancer, particularly in children and young adults.\n\nThe cancers most often associated with Li-Fraumeni syndrome include breast cancer, a form of bone cancer called osteosarcoma, and cancers of soft tissues (such as muscle) called soft tissue sarcomas. Other cancers commonly seen in this syndrome include brain tumors, cancers of blood-forming tissues (leukemias), and a cancer called adrenocortical carcinoma that affects the outer layer of the adrenal glands (small hormone-producing glands on top of each kidney). Several other types of cancer also occur more frequently in people with Li-Fraumeni syndrome.\n\nA very similar condition called Li-Fraumeni-like syndrome shares many of the features of classic Li-Fraumeni syndrome. Both conditions significantly increase the chances of developing multiple cancers beginning in childhood; however, the pattern of specific cancers seen in affected family members is different.

Professional guidelines

PubMed

van den Bent MJ, Geurts M, French PJ, Smits M, Capper D, Bromberg JEC, Chang SM
Lancet 2023 Oct 28;402(10412):1564-1579. Epub 2023 Sep 19 doi: 10.1016/S0140-6736(23)01054-1. PMID: 37738997
Xu S, Tang L, Li X, Fan F, Liu Z
Cancer Lett 2020 Apr 28;476:1-12. Epub 2020 Feb 7 doi: 10.1016/j.canlet.2020.02.002. PMID: 32044356
de Blank P, Bandopadhayay P, Haas-Kogan D, Fouladi M, Fangusaro J
Curr Opin Pediatr 2019 Feb;31(1):21-27. doi: 10.1097/MOP.0000000000000717. PMID: 30531227Free PMC Article

Curated

Febbo PG, Ladanyi M, Aldape KD, De Marzo AM, Hammond ME, Hayes DF, Iafrate AJ, Kelley RK, Marcucci G, Ogino S, Pao W, Sgroi DC, Birkeland ML
J Natl Compr Canc Netw 2011 Nov;9 Suppl 5:S1-32; quiz S33. doi: 10.6004/jnccn.2011.0137. PMID: 22138009

NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) Central Nervous System Cancers, 2023

UK NICE Guideline NG99, Brain tumours (primary) and brain metastases in over 16s, 2021

Recent clinical studies

Etiology

Jayaram MA, Phillips JJ
Annu Rev Pathol 2024 Jan 24;19:181-201. Epub 2023 Oct 13 doi: 10.1146/annurev-pathmechdis-051122-110348. PMID: 37832944
Nicholson JG, Fine HA
Cancer Discov 2021 Mar;11(3):575-590. Epub 2021 Feb 8 doi: 10.1158/2159-8290.CD-20-1474. PMID: 33558264
Molinaro AM, Taylor JW, Wiencke JK, Wrensch MR
Nat Rev Neurol 2019 Jul;15(7):405-417. Epub 2019 Jun 21 doi: 10.1038/s41582-019-0220-2. PMID: 31227792Free PMC Article
Davis ME
Semin Oncol Nurs 2018 Dec;34(5):420-429. Epub 2018 Nov 2 doi: 10.1016/j.soncn.2018.10.001. PMID: 30392758
Ostrom QT, Bauchet L, Davis FG, Deltour I, Fisher JL, Langer CE, Pekmezci M, Schwartzbaum JA, Turner MC, Walsh KM, Wrensch MR, Barnholtz-Sloan JS
Neuro Oncol 2014 Jul;16(7):896-913. doi: 10.1093/neuonc/nou087. PMID: 24842956Free PMC Article

Diagnosis

Wang LM, Englander ZK, Miller ML, Bruce JN
Adv Exp Med Biol 2023;1405:1-30. doi: 10.1007/978-3-031-23705-8_1. PMID: 37452933
Feng S, Liu Y
Adv Exp Med Biol 2021;1280:261-276. doi: 10.1007/978-3-030-51652-9_18. PMID: 33791988
Molinaro AM, Taylor JW, Wiencke JK, Wrensch MR
Nat Rev Neurol 2019 Jul;15(7):405-417. Epub 2019 Jun 21 doi: 10.1038/s41582-019-0220-2. PMID: 31227792Free PMC Article
Berger MS, Weller M
Handb Clin Neurol 2016;134:ix. doi: 10.1016/B978-0-12-802997-8.09988-6. PMID: 26948370
Henson JW, Gonzalez RG
Handb Clin Neurol 2012;104:109-26. doi: 10.1016/B978-0-444-52138-5.00008-6. PMID: 22230438

Therapy

Manoharan N, Liu KX, Mueller S, Haas-Kogan DA, Bandopadhayay P
Neoplasia 2023 Feb;36:100857. Epub 2022 Dec 24 doi: 10.1016/j.neo.2022.100857. PMID: 36566593Free PMC Article
Bien CG
Curr Opin Neurol 2021 Apr 1;34(2):166-171. doi: 10.1097/WCO.0000000000000909. PMID: 33464762
Alexiou GA, Lianos GD, Ragos V, Galani V, Kyritsis AP
Future Oncol 2017 Apr;13(9):809-819. Epub 2017 Jan 27 doi: 10.2217/fon-2016-0266. PMID: 28125906
Lin NU, Lee EQ, Aoyama H, Barani IJ, Barboriak DP, Baumert BG, Bendszus M, Brown PD, Camidge DR, Chang SM, Dancey J, de Vries EG, Gaspar LE, Harris GJ, Hodi FS, Kalkanis SN, Linskey ME, Macdonald DR, Margolin K, Mehta MP, Schiff D, Soffietti R, Suh JH, van den Bent MJ, Vogelbaum MA, Wen PY; Response Assessment in Neuro-Oncology (RANO) group
Lancet Oncol 2015 Jun;16(6):e270-8. Epub 2015 May 27 doi: 10.1016/S1470-2045(15)70057-4. PMID: 26065612
Hamza MA, Gilbert M
Curr Oncol Rep 2014 Apr;16(4):379. doi: 10.1007/s11912-014-0379-z. PMID: 24510741

Prognosis

Moreira DC, Qaddoumi I, Spiller S, Bouldin TW, Davidson A, Saba-Silva N, Sullivan DV, Tanaka R, Wagner AS, Wood M, Klimo P, Job G, Devidas M, Li X, Gajjar A, Robinson GW, Chiang J
Neuro Oncol 2024 Jul 5;26(7):1327-1334. doi: 10.1093/neuonc/noae048. PMID: 38466086Free PMC Article
Ostrom QT, Gittleman H, Stetson L, Virk SM, Barnholtz-Sloan JS
Cancer Treat Res 2015;163:1-14. doi: 10.1007/978-3-319-12048-5_1. PMID: 25468222
Curless RG, Siatkowski M, Glaser JS, Shatz NJ
Pediatr Neurol 1998 Mar;18(3):269-71. doi: 10.1016/s0887-8994(97)00189-6. PMID: 9568928
Packer RJ, Nicholson HS, Vezina LG, Johnson DL
Neurosurg Clin N Am 1992 Oct;3(4):863-79. PMID: 1392581
Lassouw GM, Twijnstra A, Schouten LJ, van de Pol M
Neuroepidemiology 1992;11(4-6):261-6. doi: 10.1159/000110939. PMID: 1291890

Clinical prediction guides

Prost D, Bielle F, Ligon KL, Touat M
Curr Opin Oncol 2021 Nov 1;33(6):626-634. doi: 10.1097/CCO.0000000000000787. PMID: 34651608
Li G, Wu F, Zeng F, Zhai Y, Feng Y, Chang Y, Wang D, Jiang T, Zhang W
CNS Neurosci Ther 2021 Feb;27(2):186-195. Epub 2020 Oct 16 doi: 10.1111/cns.13464. PMID: 33063446Free PMC Article
Erker C, Tamrazi B, Poussaint TY, Mueller S, Mata-Mbemba D, Franceschi E, Brandes AA, Rao A, Haworth KB, Wen PY, Goldman S, Vezina G, MacDonald TJ, Dunkel IJ, Morgan PS, Jaspan T, Prados MD, Warren KE
Lancet Oncol 2020 Jun;21(6):e317-e329. doi: 10.1016/S1470-2045(20)30173-X. PMID: 32502458
Fangusaro J, Witt O, Hernáiz Driever P, Bag AK, de Blank P, Kadom N, Kilburn L, Lober RM, Robison NJ, Fisher MJ, Packer RJ, Young Poussaint T, Papusha L, Avula S, Brandes AA, Bouffet E, Bowers D, Artemov A, Chintagumpala M, Zurakowski D, van den Bent M, Bison B, Yeom KW, Taal W, Warren KE
Lancet Oncol 2020 Jun;21(6):e305-e316. doi: 10.1016/S1470-2045(20)30064-4. PMID: 32502457
Davis ME
Semin Oncol Nurs 2018 Dec;34(5):420-429. Epub 2018 Nov 2 doi: 10.1016/j.soncn.2018.10.001. PMID: 30392758

Recent systematic reviews

Koekkoek JAF, van der Meer PB, Pace A, Hertler C, Harrison R, Leeper HE, Forst DA, Jalali R, Oliver K, Philip J, Taphoorn MJB, Dirven L, Walbert T
Neuro Oncol 2023 Mar 14;25(3):447-456. doi: 10.1093/neuonc/noac216. PMID: 36271873Free PMC Article
Jiménez-Morales JM, Hernández-Cuenca YE, Reyes-Abrahantes A, Ruiz-García H, Barajas-Olmos F, García-Ortiz H, Orozco L, Quiñones-Hinojosa A, Reyes-González J, Abrahantes-Pérez MDC
J Control Release 2022 Sep;349:712-730. Epub 2022 Jul 30 doi: 10.1016/j.jconrel.2022.07.027. PMID: 35905783
Efferth T, Oesch F
Semin Cancer Biol 2022 May;80:39-57. Epub 2020 Feb 4 doi: 10.1016/j.semcancer.2020.01.015. PMID: 32027979
Wu W, Klockow JL, Zhang M, Lafortune F, Chang E, Jin L, Wu Y, Daldrup-Link HE
Pharmacol Res 2021 Sep;171:105780. Epub 2021 Jul 21 doi: 10.1016/j.phrs.2021.105780. PMID: 34302977Free PMC Article
Li Y, Zhang ZX, Huang GH, Xiang Y, Yang L, Pei YC, Yang W, Lv SQ
J Clin Neurosci 2021 Jan;83:71-76. Epub 2021 Jan 7 doi: 10.1016/j.jocn.2020.11.025. PMID: 33358091

Supplemental Content

Table of contents

    Clinical resources

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.
    • Bookshelf
      See practice and clinical guidelines in NCBI Bookshelf. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Curated

    • NCCN, 2023
      NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) Central Nervous System Cancers, 2023
    • NICE, 2021
      UK NICE Guideline NG99, Brain tumours (primary) and brain metastases in over 16s, 2021
    • NCCN, 2011
      NCCN Task Force report: Evaluating the clinical utility of tumor markers in oncology.

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...